Browse the full record of transactions filed by Lian Brian, Chairman & CEO. Director active across 1 companies, notably Viking Therapeutics, Inc.. Cumulatively, 4 filings have been published. The latest transaction was disclosed on 3 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
4 of 4 declarations
Brian Lian is the President and Chief Executive Officer of Viking Therapeutics, Inc. He leads the company in its efforts to develop innovative treatments in the healthcare sector. Under his leadership, Viking Therapeutics focuses on research and development of therapeutic solutions that address unmet patient needs. Brian is recognized for his strategic vision and commitment to innovation in the biopharmaceutical industry.